G01N 33/9433
Adrenaline
Official title: {(Nor)adrenaline}
G01N33/9433 (Adrenaline) appears on 39 US grants and 51 published applications in this corpus.
Search patents in G01N- Granted patents
- 39
- Published applications
- 51
- Assignees
- 44
- Inventors
- 115
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 4 |
| 2004 | 1 | 4 |
| 2005 | 1 | 1 |
| 2006 | 2 | 5 |
| 2007 | 0 | 5 |
| 2008 | 2 | 2 |
| 2009 | 4 | 1 |
| 2010 | 3 | 1 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 2 | 2 |
| 2014 | 0 | 3 |
| 2015 | 1 | 2 |
| 2016 | 3 | 1 |
| 2017 | 0 | 2 |
| 2018 | 1 | 3 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 2 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Allosteric activators of the ALPHA1A-adrenergic receptor12 Aug 2025US 12,384,751 B2The Cleveland Clinic Foundation
- Methods for assessing efficacy of renal neuromodulation and associated systems and devices25 Mar 2025US 12,257,433 B2Medtronic Ireland Manufacturing Unlimited Company
- Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer5 Dec 2023US 11,834,489 B2Cornell University
- Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment13 Dec 2022US 11,524,073 B2
- Methods for assessing efficacy of renal neuromodulation and associated systems and devices26 Oct 2021US 11,154,712 B2Medtronic Ardian Luxembourg S.a.r.l.
- Biomarkers for diagnosis and treatment of endocrine hypertension, and methods of identification thereof28 May 2026US 2026/0148848 A1Assistance Publique-Hopitaux de Paris
- Method for providing information for brain doping diagnosis1 Jan 2026US 2026/0002951 A1Korea Institute of Science and Technology
- Biosensors for detecting changes in the level of a neurotransmitter in the central nervous system9 Nov 2023US 2023/0358770 A1
- Methods for opiate and opioid overdose prevention and reversal23 Mar 2023US 2023/0091671 A1Torralva Medical Therapeutics LLC
- Allosteric activators of the alpha1a-adrenergic receptor21 Jul 2022US 2022/0227717 A1The Clevland clinic Foundatio
Most cited
By later US patents
- Biphenyl derivatives85US 7,141,671 B2Theravance, Inc. · 2006
- Biphenyl derivatives34US 7,345,175 B2Theravance, Inc. · 2008
- Biphenyl derivatives29US 7,355,046 B2Theravance, Inc. · 2008
- Biphenyl derivatives26US 7,521,561 B2Theravance, Inc. · 2009
- Biphenyl derivatives26US 7,524,959 B2Theravance, Inc. · 2009